IGFBP5 and Glucose intolerance: IGFBP5 gene expression was successfully downregulated in TMSCs following 80 nM siRNA treatment (Figure 7A), and IGFBP5 knockdown partially reversed the protective effects of TMSCs on HFD-induced glucose intolerance (Figure 7B).